Skip to main content

Table 2 Serum lipids and oxLDL Abs among the groups

From: Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model

Serum lipids Time C H HUF HF HIF
TC       
(mg/dL) T0 49.0 ± 3.7aA 42.0 ± 2.8aB 44.8 ± 5.8aB 45.3 ± 5.1aB 44.5 ± 5.4aB
  T60 53.3 ± 6.2bA 2556.5 ± 120.3aA 1876.3 ± 233.6bA 1583.8 ± 86.3cA 1867.5 ± 251.7bA
HDL-C       
(mg/dL) T0 31.5 ± 2.3aA 28.5 ± 2.5 aA 31.50 ± 3.6aA 32.0 ± 2.6aA 31.8 ± 1.1aA
  T60 26.8 ± 2.8aA 16.8 ± 2.8cB 22.8 ± 2.8abB 32.0 ± 2.6aA 26.0 ± 2.1aB
n-HDL-C       
(mg/dL) T0 17.5 ± 2.6aB 13.5 ± 2.9aB 13.3 ± 2.4aB 13.3 ± 3.0aB 12.3 ± 2.3aB
  T60 26.5 ± 4.4cA 2539.8 ± 120.2aA 1853.5 ± 231.8bA 1557.8 ± 86.6bA 1841.5 ± 249.8bA
oxLDL Abs       
(mAU/L) T0 0.204 ± 0.104aA 0.339 ± 0.129aB 0.323 ± 0.105aB 0.390 ± 0.289aA 0.338 ± 0.166aA
  T60 0.316 ± 0.156bA 1.809 ± 0.514aA 0.799 ± 0.285bA 0.553 ± 0.296bA 0.530 ± 0.232bA
  1. Values (in mg/dL) represent mean ± SEM (n = 6). C = control; H = hypercholesterolemic; HUF = hypercholesterolemic plus unfermented soy product, HF = hypercholesterolemic plus fermented soy product, HIF = hypercholesterolemic plus isoflavone-supplemented fermented soy product. T0 = before the start of the study, T60 = end of the experiment. Statistical comparison of treatment groups: means with identical lower-case letters in the same row do not differ significantly (P ≤ 0.05). Statistical comparison of times: means with identical upper-case letters in the same column do not differ significantly (P ≤ 0.05).